Jeon, Y.-H.; Lee, N.; Yoo, J.; Won, S.; Shin, S.-k.; Kim, K.-H.; Park, J.-G.; Kim, M.-G.; Kim, H.-R.; Oh, K.;
et al. Oncolytic Vaccinia Virus Augments T Cell Factor 1-Positive Stem-like CD8+ T Cells, Which Underlies the Efficacy of Anti-PD-1 Combination Immunotherapy. Biomedicines 2022, 10, 805.
https://doi.org/10.3390/biomedicines10040805
AMA Style
Jeon Y-H, Lee N, Yoo J, Won S, Shin S-k, Kim K-H, Park J-G, Kim M-G, Kim H-R, Oh K,
et al. Oncolytic Vaccinia Virus Augments T Cell Factor 1-Positive Stem-like CD8+ T Cells, Which Underlies the Efficacy of Anti-PD-1 Combination Immunotherapy. Biomedicines. 2022; 10(4):805.
https://doi.org/10.3390/biomedicines10040805
Chicago/Turabian Style
Jeon, Yun-Hui, Namhee Lee, Jiyoon Yoo, Solchan Won, Suk-kyung Shin, Kyu-Hwan Kim, Jun-Gyu Park, Min-Gang Kim, Hang-Rae Kim, Keunhee Oh,
and et al. 2022. "Oncolytic Vaccinia Virus Augments T Cell Factor 1-Positive Stem-like CD8+ T Cells, Which Underlies the Efficacy of Anti-PD-1 Combination Immunotherapy" Biomedicines 10, no. 4: 805.
https://doi.org/10.3390/biomedicines10040805
APA Style
Jeon, Y. -H., Lee, N., Yoo, J., Won, S., Shin, S. -k., Kim, K. -H., Park, J. -G., Kim, M. -G., Kim, H. -R., Oh, K., & Lee, D. -S.
(2022). Oncolytic Vaccinia Virus Augments T Cell Factor 1-Positive Stem-like CD8+ T Cells, Which Underlies the Efficacy of Anti-PD-1 Combination Immunotherapy. Biomedicines, 10(4), 805.
https://doi.org/10.3390/biomedicines10040805
